SUBSCRIBE
SUBSCRIBE

Preclinical

Photo courtesy of Aridis
Business
Aridis CEO Confident Inhaled Antibody Formulation Will Play a Key Role in Controlling COVID-19
Only a fraction of intravenous antibody treatments will make their way to the lungs of COVID-19 patients, which is where the infection is primarily located. Aridis Chief Executive Officer Vu Truong believes his company has a better solution – an inhaled antibody.
October 26, 2020
 · 
3 min read
 · 
Alex Keown
Drug Development
Biopharma Update on the Novel Coronavirus: October 20
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 20, 2020.
October 20, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: October 13
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 13, 2020.
October 13, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: October 6
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 6, 2020.
October 6, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Arcturus CEO: Investigational COVID-19 Vaccine Could Play Notable Role in Managing the Pandemic
Arcturus CEO Joseph Payne told BioSpace in an interview that his company’s vaccine candidate is a low-dose, single-shot treatment that generated not only neutralizing antibody titers, but also CD8+ T-cell induction in preclinical studies.
September 22, 2020
 · 
3 min read
 · 
Alex Keown
Policy
Biopharma Update on the Novel Coronavirus: October 2
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 2, 2020.
September 22, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: September 30
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 30, 2020.
September 22, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: September 28
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 28, 2020.
September 22, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: September 25
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 25, 2020.
September 22, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: September 23
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 23, 2020.
September 22, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Press Releases
Vittoria Biotherapeutics Presents Positive Preclinical Data at 66th Annual ASH Meeting Supporting its Novel Approach to Engineered CAR-T Cell Therapies
December 9, 2024
 · 
4 min read
Press Releases
BBO-8520 Preclinical Data Published in Cancer Discovery Supports the Potential for the First-in-Class Molecule to Provide Therapeutic Benefit in KRASG12C Mutant Tumors
December 9, 2024
 · 
4 min read
Press Releases
Seismic Therapeutic Presents New Preclinical Efficacy Data for S-1117 in Prophylactic and Therapeutic Animal Models of Immune Thrombocytopenia (ITP) at 66th ASH Annual Meeting
December 9, 2024
 · 
3 min read
Press Releases
Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures
December 9, 2024
 · 
8 min read
Press Releases
New Preclinical Data Demonstrate Potential of Capsida’s IV Gene Therapy for STXBP1-DEE to Correct all Disease Manifestations
December 9, 2024
 · 
4 min read
Press Releases
NurExone Announces Promising Preclinical Results in Restoring Vision After Optic Nerve Damage
December 9, 2024
 · 
9 min read
Press Releases
Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024
December 9, 2024
 · 
11 min read
Press Releases
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND
December 9, 2024
 · 
5 min read
Press Releases
Y-mAbs Presents SADA Platform Preclinical Data and Trial in Progress Posters at the 2024 American Society Hematology (ASH) Annual Meeting
December 9, 2024
 · 
8 min read
Press Releases
MiNA Therapeutics Presents New Pre-Clinical Data from Lead Sickle Cell Disease Program at the American Society of Hematology Annual Meeting
December 9, 2024
 · 
3 min read
Press Releases
ReAlta Life Sciences Announces Positive Preclinical Data for RLS-0071 (pegtarazimod) in Acute Graft-Versus-Host Disease (aGVHD) at American Society of Hematology Annual Meeting
December 9, 2024
 · 
4 min read
Press Releases
Vanqua Bio to Present Pre-Clinical Data on VQ-201, a Next Generation C5aR1 Antagonist for the Treatment of Inflammatory Disorders
December 5, 2024
 · 
2 min read
Press Releases
Bispecific Antibody, APVO442, Differentiated to Treat Prostate Cancer with Precision Tumor Targeting and Reduced Risk of Side Effects
December 5, 2024
 · 
7 min read
Press Releases
Corvus Pharmaceuticals Announces Publication of Biochemistry and Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Modulate Tumor Immunity
December 5, 2024
 · 
6 min read
Press Releases
NLS Pharmaceutics Announces Promising Preclinical Data for First-in-Class Non-Sulfonamide, Dual Orexin Receptor Agonists for the Potential Treatment of Narcolepsy and Neurological Disorders
December 3, 2024
 · 
5 min read
Press Releases
Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1
December 3, 2024
 · 
8 min read
Press Releases
AlveoGene’s Novel, Inhaled Gene Therapy AVG-002 Receives Orphan Drug Designation from FDA for Lethal Neonatal Surfactant Protein B (SP-B) Deficiency
December 3, 2024
 · 
5 min read
Press Releases
Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-life Extended Anti-TL1A Antibodies
December 3, 2024
 · 
8 min read
Press Releases
Solu Therapeutics to Present First Preclinical Data of STX-0712 for the Treatment of Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting
December 2, 2024
 · 
2 min read
Press Releases
Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress
December 2, 2024
 · 
3 min read
Load More